Name | Number of supported studies | Average coverage | |
---|---|---|---|
squamous epithelial cell | 4 studies | 50% ± 14% | |
epithelial cell | 3 studies | 30% ± 10% | |
ciliated cell | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of TP53INP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 34895.89 | 2641 / 2642 | 100% | 131.65 | 705 / 705 |
prostate | 99% | 7666.43 | 242 / 245 | 100% | 64.35 | 501 / 502 |
kidney | 99% | 4745.11 | 88 / 89 | 99% | 79.63 | 894 / 901 |
adrenal gland | 98% | 4967.89 | 252 / 258 | 99% | 70.30 | 228 / 230 |
esophagus | 99% | 10782.25 | 1434 / 1445 | 97% | 82.83 | 177 / 183 |
thymus | 99% | 6640.48 | 648 / 653 | 94% | 40.04 | 570 / 605 |
intestine | 99% | 7067.90 | 954 / 966 | 93% | 37.68 | 488 / 527 |
lung | 93% | 3722.04 | 535 / 578 | 95% | 43.54 | 1103 / 1155 |
liver | 83% | 2991.38 | 188 / 226 | 97% | 44.86 | 394 / 406 |
uterus | 93% | 4166.58 | 158 / 170 | 85% | 37.27 | 388 / 459 |
breast | 80% | 2516.65 | 365 / 459 | 95% | 43.71 | 1067 / 1118 |
bladder | 86% | 6211.81 | 18 / 21 | 86% | 29.92 | 431 / 504 |
stomach | 76% | 3616.07 | 272 / 359 | 95% | 50.76 | 272 / 286 |
ovary | 69% | 2527.06 | 125 / 180 | 86% | 26.89 | 369 / 430 |
skin | 49% | 1456.83 | 885 / 1809 | 100% | 53.12 | 470 / 472 |
pancreas | 7% | 174.37 | 24 / 328 | 97% | 37.30 | 172 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.39 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 98% | 38.31 | 78 / 80 |
heart | 96% | 9617.25 | 827 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 47.52 | 42 / 45 |
blood vessel | 91% | 3955.65 | 1213 / 1335 | 0% | 0 | 0 / 0 |
adipose | 86% | 3305.86 | 1030 / 1204 | 0% | 0 | 0 / 0 |
muscle | 85% | 5253.61 | 686 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 10.65 | 18 / 29 |
spleen | 16% | 391.32 | 38 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 138.37 | 56 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0008104 | Biological process | protein localization |
GO_0001894 | Biological process | tissue homeostasis |
GO_1903828 | Biological process | negative regulation of protein localization |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0000045 | Biological process | autophagosome assembly |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0005829 | Cellular component | cytosol |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016605 | Cellular component | PML body |
GO_0005776 | Cellular component | autophagosome |
GO_0005634 | Cellular component | nucleus |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TP53INP2 |
Protein name | Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U) Tumor protein p53 inducible nuclear protein 2 |
Synonyms | PINH DOR C20orf110 |
Description | FUNCTION: Dual regulator of transcription and autophagy. Positively regulates autophagy and is required for autophagosome formation and processing. May act as a scaffold protein that recruits MAP1LC3A, GABARAP and GABARAPL2 and brings them to the autophagosome membrane by interacting with VMP1 where, in cooperation with the BECN1-PI3-kinase class III complex, they trigger autophagosome development. Acts as a transcriptional activator of THRA. . |
Accessions | Q5JX65 ENST00000414082.1 ENST00000374809.6 ENST00000451665.5 Q5JX66 Q8IXH6 ENST00000374810.8 |